Patents
US 12296002 B2: Immunogenic composition against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- Granted
- 2025-05-13
- Filed
- 2021-06-18 application 17351363
- Type
- Utility · 14 claims
- Elsewhere
- Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗
Abstract
The present invention relates to an immunogenic composition against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), especially to an immunogenic composition having a recombinant SARS-CoV-2 S protein and adjuvant.
Source: PVGPATDIS, file of 2026-04-10 (ipg250513.xml).
Assignees
| Assignee | Type | Place | Also on furp.org | Source |
|---|---|---|---|---|
| MEDIGEN VACCINE BIOLOGICS CORPORATION 1 patents | Foreign company or organization | Zhubeikou, TW | PVGPATDIS, file of 2026-04-10 | |
| DYNAVAX TECHNOLOGIES CORPORATION 50 patents | US company or organization | Emeryville, CA | DYNAVAX TECHNOLOGIES CORP SEC filer FUZZY low confidence: same name (legal endings aside), one of each nationally | PVGPATDIS, file of 2026-04-10 |
Inventors
| Inventor | Place | Patents | Person page | Source |
|---|---|---|---|---|
| Tsun-Yung Kuo | Sanjiaopu, TW | 11 | PVGPATDIS, file of 2026-04-10 | |
| Charles CHEN | Taipei, TW | 2 | PVGPATDIS, file of 2026-04-10 | |
| Chung-Chin Wu | Sanjiaopu, TW | 6 | PVGPATDIS, file of 2026-04-10 | |
| Yi-Jiun Lin | Taipei, TW | 12 | PVGPATDIS, file of 2026-04-10 | |
| Meei-Yun Lin | Taipei, TW | 1 | PVGPATDIS, file of 2026-04-10 | |
| Yu-Chi Wu | Taipei, TW | 34 | PVGPATDIS, file of 2026-04-10 | |
| John D. CAMPBELL | Emeryville, CA | 3 | PVGPATDIS, file of 2026-04-10 | |
| Robert Janssen | Emeryville, CA | 9 | PVGPATDIS, file of 2026-04-10 | |
| David Novack | Emeryville, CA | 4 | PVGPATDIS, file of 2026-04-10 | |
| Robert L. Coffman | Emeryville, CA | 23 | PVGPATDIS, file of 2026-04-10 | |
| Paula Traquina | Emeryville, CA | 1 | PVGPATDIS, file of 2026-04-10 |
CPC categories
| Subclass | Category | First group | Source |
|---|---|---|---|
| A61K | Preparations for medical, dental or toiletry purposes | A61K39/12 | PVGPATDIS, file of 2026-04-10 |
| A61P | Specific therapeutic activity of chemical compounds or medicinal preparations | A61P31/14 | PVGPATDIS, file of 2026-04-10 |
| C07K | Peptides | C07K14/005 | PVGPATDIS, file of 2026-04-10 |
| C12N | Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media | C12N2770/20022 | PVGPATDIS, file of 2026-04-10 |
Cooperative Patent Classification, as currently assigned (one row per subclass).
Assignments and security interests
| Recorded | What | From | To | Reel/frame | Source |
|---|---|---|---|---|---|
| 2023-03-07 | Assignment Assignment of assignor's interest | COFFMAN, ROBERT signed 2023-02-02 TRAQUINA, PAULA signed 2023-02-02 | DYNAVAX TECHNOLOGIES CORPORATION EMERYVILLE, CA | 62908/693 | ECORSEXC, file of 2026-09-25 |
| 2021-10-11 | Assignment Assignment of assignor's interest | LIN, MEEI-YUN signed 2021-07-02 LIN, YI-JIUN signed 2021-07-02 WU, CHUNG-CHIN signed 2021-07-02 WU, YU-CHI signed 2021-07-02 CHEN, CHARLES signed 2021-07-05 KUO, TSUN-YUNG signed 2021-07-08 JANSSEN, ROBERT S. signed 2021-09-16 NOVACK, DAVID signed 2021-09-16 CAMPBELL, JOHN DARREN signed 2021-09-17 | DYNAVAX TECHNOLOGIES CORPORATION EMERYVILLE, CA MEDIGEN VACCINE BIOLOGICS CORPORATION ZHUBEI CITY, HSINCHU COUNTY | 57750/37 | ECORSEXC, file of 2026-09-25 |
Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.
USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.